Download PDF
Thromb Haemost 1985; 53(01): 099-104
DOI: 10.1055/s-0038-1661245
Original Article
Schattauer GmbH Stuttgart

PAF-Acether May Not Mediate the Third Pathway of Platelet Aggregation since Self-Desensitization Reduces the Effects of Low Thrombin but Enhances Those of Convulxin

Françoise Wal
The Unité des Venins, Département de Physiopathologie expérimentale. Institut Pasteur, Paris, France
,
Danielle Joseph
The Unité des Venins, Département de Physiopathologie expérimentale. Institut Pasteur, Paris, France
,
Lhousseine Touqui
The Unité des Venins, Département de Physiopathologie expérimentale. Institut Pasteur, Paris, France
,
B Boris Vargaftig
The Unité des Venins, Département de Physiopathologie expérimentale. Institut Pasteur, Paris, France
› Author Affiliations
Further Information

Publication History

Received 30 July 1984

Accepted 13 November 1984

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

PAF-acether (platelet-activating factor) was hypothesized as the mediator of the ADP and thromboxane-independent activation of platelets induced by thrombin (Thr) and by the snake venom glycoprotein convulxin (Cx). Aspirinized rabbit platelets self-desensitized to PAF-acether were less responsive to low amounts of Thr, as expected if PAF-acether would be formed, but were hyper-reactive to Cx, in contradiction with its hypothesized mediating role. Aggregation by higher concentrations of Thr overcame inhibition. Experiments with ADP-depleted platelets showed that secretion is neither involved with desensitization to PAF-acether nor with hyper-reactivity to Cx. Those effects required the presence of PAF-acether in the platelet suspension and persisted when transformation of PAF-acether into its recognized metabolite alkyl-acyl-glycerophosphorylcholine was inhibited. The ADP and thromboxane-independent activation of rabbit platelets by low and medium concentrations of Thr may be accounted for by platelet formation of PAF-acether, but overall the contrasting effects of platelet desensitization to PAF-acether on responsiveness to Thr and to Cx suggest that the third pathway of aggregation requires other explanations.

Key words

ADP - Convulxin - PAF-acether (platelet-activating factor) - Thromboxane - Thrombin - Rabbit platelets
 

  • References

  • 1 Benveniste J, Henson PM, Cochrane CG. Leucocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils and platelet-activating factor J Exp Med 1972; 136: 1356-1376
    CrossrefPubMedGoogle Scholar
  • 2 Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet activating factor. Evidence for l-0-alkyl-2-acetyl-sn-glyceryl-3-phosphoryl- choline as the active component (a new class of lipid chemical mediators) J Biol Chem 1979; 254: 9355-9358
    PubMedGoogle Scholar
  • 3 Mencia-Huerta JM, Benveniste J. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur J Immunol 1979; 9: 409-415
    CrossrefPubMedGoogle Scholar
  • 4 Camussi G, Bussolino F, Tetta C, Piacibello W, Aglietta M. Biosynthesis and release of platelet-activating factor from human monocytes. Int Arch Allergy Appl Immunol 1983; 70: 245-251
    CrossrefPubMedGoogle Scholar
  • 5 Chignard M, Le Couedic JP, Vargaftig BB, Benveniste J. Plateletactivating factor (PAF-acether) secretion from platelets. Effect of aggregating agents Br J Haematol 1980; 46: 455-464
    CrossrefPubMedGoogle Scholar
  • 6 Vargaftig BB, Joseph D, Wal F, Marlas G, Chignard M, Chevance LG. Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitization with collagen. Eur J Pharmacol 1983; 92: 57-68
    CrossrefPubMedGoogle Scholar
  • 7 Chignard M, Le Couedic JP, Vargaftig BB, Tencé M, Benveniste J. The role of platelet-activating factor in platelet aggregation. Nature 1979; 179: 799-800
    PubMedGoogle Scholar
  • 8 Vargaftig BB, Chignard M, Le Couedic JP, Benveniste J. One, two, three or more pathways for platelet aggregation. Acta Med Scand 1980; 642: 23-29
    PubMedGoogle Scholar
  • 9 Vargaftig BB, Chignard M, Benveniste J. Present concepts on the mechanisms of platelet aggregation. Biochem Pharmacol 1981; 30: 263-271
    CrossrefPubMedGoogle Scholar
  • 10 Marlas G. Purification and preliminary structure of a potent plateletaggregating glycoprotein isolated from the venom of Crotalus durissus cascavella. Toxicon 1982; 20: 289-290
    CrossrefPubMedGoogle Scholar
  • 11 Godfroid JJ, Heymans F, Michel E, Redeuilh C, Steiner E, Benveniste J. Platelet-activating factor (PAF-acether): total synthesis of l-0-octadecyl-2-0-acetyl-sn-glycero-3-phosphorylcholine. FEBS Lett 1980; 116: 161-164
    CrossrefPubMedGoogle Scholar
  • 12 Ardlie NG, Packham MA, Mustard JF. Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol 1970; 19: 7-17
    CrossrefPubMedGoogle Scholar
  • 13 Vargaftig BB, Joseph D, Marlas G, Chevance LG. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances. Thromb Haemostas 1982; 48: 67-71
    PubMedGoogle Scholar
  • 14 Cazenave JP, Benveniste J, Mustard JF. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane active drugs. Lab Invest 1979; 41: 275-285
    PubMedGoogle Scholar
  • 15 Henson PM. Activation and desensitization of platelets by plateletactivating factor (PAF) derived from IgE sensitized basophils.I. Characteristics of the secretory response. J Exp Med 1976; 143: 937-952
    CrossrefPubMedGoogle Scholar
  • 16 Tencé M, Coeffier E, Heymans F, Polonsky J, Godfroid JJ, Benveniste J. Structural analogs of platelet-activating factor (PAF- acether). Biochimie 1981; 63: 723-727
    CrossrefPubMedGoogle Scholar
  • 17 Kinlough-Rathbone RL, Packham MA, Mustard JF. Comparison of methods of measuring loss of cytoplasmic constituents from platelets. Thromb Res 1976; 9: 669-673
    CrossrefPubMedGoogle Scholar
  • 18 Touqui L, Jacquemin C, Vargaftig BB. Conversion of 3H-PAF- acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite. Biochem Biophys Res Commun 1983; 110: 890-893
    CrossrefPubMedGoogle Scholar
  • 19 Pieroni G, Hanahan DJ. Metabolic behavior of Acetylglycerylether phosphorylcholine on interaction with rabbit platelets. Arch Biochem Biophys 1983; 224: 485-493
    CrossrefPubMedGoogle Scholar
  • 20 Detwiler TC, Feinman RD. Kinetics of the thrombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium Biochemistry 1973; 12: 2462-2468
    CrossrefPubMedGoogle Scholar
  • 21 Henson PM. Activation of platelets by platelet-activating factor (PAF) derived from IgE sensitized basophils. III. Characteristics of the aggregation and its dissociation from secretion. J Clin Invest 1977; 60: 481-490
    CrossrefPubMedGoogle Scholar
  • 22 Alam I, Smith JB, Silver MJ. Metabolism of platelet-activating factor by blood platelets and plasma. Lipids 1983; 18: 534-538
    CrossrefPubMedGoogle Scholar
  • 23 Vargaftig BB. Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitors. J Pharm Pharmacol 1977; 29: 222-228
    CrossrefPubMedGoogle Scholar
  • 24 Kinlough-Rathbone RL, Packham MA, Reimers HJ, Cazenave JP, Mustard JF. Mechanisms of platelet shape change aggregation and release induced by collagen, thrombin or A 23185. J Lab Clin Med 1977; 90: 707-719
    PubMedGoogle Scholar
  • 25 Westwick J, Mark G, Kakkar VV. The role of platelet-activating factor (PAF) in cyclooxygenase independent thrombin and collagen induced human platelet activation. Tliromb Haemostas 1983; 50: 40 (Abstr.)
    PubMedGoogle Scholar
  • 26 Blank ML, Lee TC, Fitzgerald V, Snyder F. A specific acetylhydro-lase for l-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and Platelet-activating lipid). J Biol Chem 1981; 256: 175-178
    PubMedGoogle Scholar
  • 27 Touqui L, Jacquemin C, Dumarey C, Vargaftig BB. l-0-alkyl-2-acyl- sn-glycero-3-phosphorylcholine is the precursor of PAF-acether in rabbit stimulated platelets: evidences for a PAF-acether cycle. Biochem Biophys Acta. (in press)
    PubMedGoogle Scholar
  • 28 Vargaftig BB, Fouque F, Benveniste J, Odiot J. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. Thromb Res 1982; 28: 557-573
    CrossrefPubMedGoogle Scholar